The Investigator Initiated Research Award (IIRA) supports highly rigorous, high-impact research projects that have the potential to make an important contribution to MS research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials.
Proposals must address the treatment of MS Symptoms, which may include: Pain, Fatigue, Cognitive Dysfunction, Visual Impairment, Motor Impairment, Impaired Mobility, Loss of Bladder Control, Sexual Dysfunction, Depression, and Anxiety.
Funding & Duration
The maximum period of performance is 3 years. The anticipated direct costs budgeted for the entire period of performance will not exceed US $600,000 (approx. AUD $770,000).
Funding may be used for salary, research supplies, research-related subject costs, clinical research costs, travel between collaborating organisations, travel costs for up to 2 investigators to travel to 1 scientific/technical meeting per year.
Preclinical research studies are not eligible for funding.
Primary Investigators (PIs) must be independent investigators at or above the level of Assistant Professor (or equivalent).
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Submission Requirements & Due Dates
- 26 May 2016 – pre-proposal submitted via https://eBRAP.org.
- Copy of pre-proposal forwarded to the Research Branch ASAP.
- 15 August 2016 – full applications (by invitation only) submitted to the Research Branch for internal review.
- Grants Officer: Dr Don McMaster
- Email: firstname.lastname@example.org